Michael K. Samson
- Oncology top 10%
- Lung Cancer Research Studies 10
- Cancer Treatment and Pharmacology 5
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 6
-
- Lung Cancer Treatments and Mutations 9
- Neurology top 10%
- Surgery top 10%
- Testicular diseases and treatments 5
-
- Cancer therapeutics and mechanisms 8
-
- Neuroendocrine Tumor Research Advances 4
-
- Cancer Research and Treatments 3
Michael K. Samson
46 papers receiving 883 citations
Peers
Comparison fields: 5 of 88
- Oncology 361
- Reproductive Medicine 76
- Pulmonary and Respiratory Medicine 294
- Neurology 132
- Surgery 325
Countries citing papers authored by Michael K. Samson
This map shows the geographic impact of Michael K. Samson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael K. Samson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael K. Samson more than expected).
Fields of papers citing papers by Michael K. Samson
This network shows the impact of papers produced by Michael K. Samson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael K. Samson. The network helps show where Michael K. Samson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael K. Samson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 1993 | 5 | |
| 4 | 1991 | 10 | |
| 5 | 1991 | 31 | |
| 6 | 1991 | 35 | |
| 7 | 1991 | 35 | |
| 8 | 1987 | 58 | |
| 9 | 1987 | 2 | |
| 10 | 1987 | 10 | |
| 11 | 1987 | 1 | |
| 12 | 1987 | 13 | |
| 13 | 1984 | 150 | |
| 14 | 1984 | 1 | |
| 15 | Clinical trial of chlorozotocin, DTIC, and dactinomycin in metastatic malignant melanoma. | 1982 | 3 |
| 16 | 1980 | 85 | |
| 17 | Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma. | 1976 | 2 |
| 18 | Hepatic artery infusion of 5-FUDR after prior systemic 5-fluorouracil. | 1976 | 18 |
| 19 | 1975 | 26 | |
| 20 | 1963 | 48 |
About Michael K. Samson
Michael K. Samson is a scholar working on Reproductive Medicine, Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Biotechnology, having authored 51 papers that have together received 981 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (9 papers), Cancer therapeutics and mechanisms (8 papers), Ovarian cancer diagnosis and treatment (6 papers), Testicular diseases and treatments (5 papers), Cancer Treatment and Pharmacology (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Oncology (361 citations), Reproductive Medicine (76 citations), Pulmonary and Respiratory Medicine (294 citations), Neurology (132 citations) and Surgery (325 citations). Michael K. Samson has collaborated with scholars based in United States, Pakistan and Nigeria. Frequent co-authors include Laurence H. Baker, Ronald L. Stephens, Lynn G. Feun, Saul E. Rivkin, Glenn Cummings, Albert F. LoBuglio, John J. Costanzi, Edmund A. Gehan, Stephen E. Jones and Paul V. Woolley. Their work appears in journals such as Cancer, Investigational New Drugs, Journal of Clinical Oncology, American Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.